Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2010 | 2 |
2011 | 3 |
2014 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
NFAT as cancer target: mission possible?
Biochim Biophys Acta. 2014 Dec;1846(2):297-311. doi: 10.1016/j.bbcan.2014.07.009. Epub 2014 Jul 26.
Biochim Biophys Acta. 2014.
PMID: 25072963
Free PMC article.
Review.
MDM2 promotes proteasomal degradation of p21Waf1 via a conformation change.
Xu H, Zhang Z, Li M, Zhang R.
Xu H, et al.
J Biol Chem. 2010 Jun 11;285(24):18407-14. doi: 10.1074/jbc.M109.059568. Epub 2010 Mar 22.
J Biol Chem. 2010.
PMID: 20308078
Free PMC article.
Item in Clipboard
The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells.
Yao HP, Zhou YQ, Ma Q, Guin S, Padhye SS, Zhang RW, Wang MH.
Yao HP, et al.
Mol Cancer. 2011 Jul 12;10:82. doi: 10.1186/1476-4598-10-82.
Mol Cancer. 2011.
PMID: 21749705
Free PMC article.
Item in Clipboard
FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer.
Wang F, Ezell SJ, Zhang Y, Wang W, Rayburn ER, Nadkarni DH, Murugesan S, Velu SE, Zhang R.
Wang F, et al.
Invest New Drugs. 2010 Jun;28(3):234-41. doi: 10.1007/s10637-009-9232-x. Epub 2009 Mar 10.
Invest New Drugs. 2010.
PMID: 19274441
Free PMC article.
Item in Clipboard
Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein.
Ma Q, Guin S, Padhye SS, Zhou YQ, Zhang RW, Wang MH.
Ma Q, et al.
Mol Cancer. 2011 May 28;10:66. doi: 10.1186/1476-4598-10-66.
Mol Cancer. 2011.
PMID: 21619683
Free PMC article.
Item in Clipboard
Efficacy of anti-RON antibody Zt/g4-drug maytansinoid conjugation (Anti-RON ADC) as a novel therapeutics for targeted colorectal cancer therapy.
Feng L, Yao HP, Wang W, Zhou YQ, Zhou J, Zhang R, Wang MH.
Feng L, et al.
Clin Cancer Res. 2014 Dec 1;20(23):6045-58. doi: 10.1158/1078-0432.CCR-14-0898. Epub 2014 Oct 7.
Clin Cancer Res. 2014.
PMID: 25294907
Item in Clipboard
Sustained expression of the RON receptor tyrosine kinase by pancreatic cancer stem cells as a potential targeting moiety for antibody-directed chemotherapeutics.
Padhye SS, Guin S, Yao HP, Zhou YQ, Zhang R, Wang MH.
Padhye SS, et al.
Mol Pharm. 2011 Dec 5;8(6):2310-9. doi: 10.1021/mp200193u. Epub 2011 Nov 1.
Mol Pharm. 2011.
PMID: 22014215
Item in Clipboard
Cite
Cite